Immuron

About:

Immuron focuses on oral immunotherapy using polyclonal antibody products for humans.

Website: http://www.immuron.com/

Twitter/X: immuronltd

Top Investors: U.S. Department of Defense, Naval Medical Research Center, Walter Reed Army Institute of Research

Description:

Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.